Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Extracorporeal Shock Wave Technology Repairs Osteoarthritis Damage

By HospiMedica International staff writers
Posted on 27 Jun 2011
A novel preclinical study suggests that extracorporeal shock wave technology (ESWT) has chondroprotective effects in the osteoarthritic rat knee.

Researchers at Kaohsiung Chang Gung Memorial Hospital (Taiwan) utilized three groups of Sprague-Dawley rats, each containing nine animals. More...
The rats in the control group did not have their anterior cruciate ligaments (ACL) surgically cut, whereas animals in the other two groups underwent surgical ACL transection (ACLT) in order to induce osteoarthritis (OA). Of the two ACLT groups, one group received a single ESWT procedure immediately following ACLT, while the other group received no treatment of any kind after ACLT. All animals underwent evaluations including radiograph, bone mineral density, serum levels of cartilage oligometric protein and osteocalcin, and urinary concentration of C-telopeptide of type II collagen (CTXII), and histomorphological examination.

The results showed that a single ESWT procedure prevented or significantly improved surgically induced OA damage to the knee in the rat model, significantly decreased articular cartilage degradation, and improved subchondral bone remodeling. When treated with ESWT, the surgically compromised OA knees displayed comparable data to the control group of normal, healthy knees at 12 weeks post-treatment. Multiple analyses of articular cartilage, subchondral bone, and blood and urine protein markers suggest that early application of ESWT provides a chondroprotective effect to prevent OA onset. The study was published on June 9, 2011, in the online edition of Archives of Orthopedic Trauma Surgery.

"Based on these positive study results, ESWT treatment may offer an effective, low-cost treatment option in humans that carries little risk compared with other treatments," said lead author orthopedic surgeon Ching-Jen Wang, MD. "This study is clinically relevant because it validates our original theory that ESWT treatment has a chondroprotective effect that repairs and prevents osteoarthritic changes in the knee joint."

ESWT is a method of treatment for multiple musculoskeletal conditions. Presently it is only approved by the US Food and Drug Administration (FDA) for treatment of plantar fasciitis and tennis elbow. ESWT probably works due to the microtrauma of the repeated shock wave to the affected area, which creates neovascularization into the area. It is this new blood flow that promotes tissue healing. A second theory is that in chronic pain, the brain has "forgotten" about the pain and is doing nothing to heal the area. By having shockwave therapy, a new inflammatory process is created and the brain can react to it by sending the necessary body nutrients to the area to promote healing.

Related Links:

Kaohsiung Chang Gung Memorial Hospital




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.